SCHEMBL4614504

SCHEMBL4614504

C1=Cc2occc2OC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1815150 0.68 CYP1A2 (0.43)
SCHEMBL9391887 0.65 CYP1A2 (0.43)
SCHEMBL9101318 0.65 CYP1A2 (0.40)
SCHEMBL2398725 0.64
SCHEMBL2374787 0.62
SCHEMBL12477741 0.61 CA1 (0.33)
SCHEMBL2289180 0.60 CYP2B6 (0.43)
SCHEMBL9208 0.60 CYP2B6 (0.43)
SCHEMBL2281562 0.60 CYP2B6 (0.43)
SCHEMBL29364609 0.60 CYP2B6 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025111482-A1 COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS BEXSON BIOMEDICAL, INC. (US) 2025-05-30 WO claimed
CN-117142917-A Method for synthesizing chiral 4-substituted 3-alkoxycarbonyl butyrolactone derivative by palladium-catalyzed asymmetric hydrogenation 中国科学院大连化学物理研究所 2023-12-01 CN claimed
CN-115613350-A Preparation method of multi-performance conductive composite flexible fabric 扬州泉生源电磁技术有限公司 2023-01-17 CN claimed
US-8969394-B2 Thiophenecarboxamide derivatives as EP4 receptor ligands MERCK FROSST CANADA LTD. (CA) 2015-03-03 US claimed
EP-0607439-B1 NITROGENOUS HETEROCYCLIC COMPOUND EISAI CO LTD (JP) 2002-01-09 EP claimed
EP-0607439-A1 NITROGENOUS HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 1994-07-27 EP claimed
US-12570668-B2 Single molecule compounds providing multi-target inhibition of BTK and other proteins and methods of use thereof SIGNALRX PHARMACEUTICALS, INC. (US) 2026-03-10 US disclosed
US-20260015508-A1 Biologically-Derived Carbon Black Alternative And Method Of Making The Same LIVING INK TECHNOLOGIES, LLC (US) 2026-01-15 US disclosed
US-12421397-B2 Biologically-derived carbon black alternative and method of making the same LIVING INK TECHNOLOGIES, LLC (US) 2025-09-23 US disclosed
WO-2025111482-A1 COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS BEXSON BIOMEDICAL, INC. (US) 2025-05-30 WO disclosed
CN-115128204-B Method for establishing pyrolysis volatile product component database of waste circuit board and application of method 中南大学 2024-07-23 CN disclosed
US-20230407099-A1 Biologically-Derived Carbon Black Alternative And Method Of Making The Same LIVING INK TECHNOLOGIES, LLC 2023-12-21 US disclosed
CN-117142917-A Method for synthesizing chiral 4-substituted 3-alkoxycarbonyl butyrolactone derivative by palladium-catalyzed asymmetric hydrogenation 中国科学院大连化学物理研究所 2023-12-01 CN disclosed
US-5693652-A Benzimidazoles for ischemic heart conditions EISAI CO., LTD. (JP) 1997-12-02 US disclosed
EP-0476457-B1 2-Benzothiazolyl tetrazolium salt indicators BAYER AG (US) 1996-12-04 EP disclosed
US-5576322-A Anti-ischemic 2,4-diaminoquinazolines EISAI CO., LTD. (JP) 1996-11-19 US disclosed
EP-0476454-B1 Analytical method using tetrazolium salt indicators having a reflectance plateau BAYER AG (US) 1996-10-23 EP disclosed
EP-0607439-A1 NITROGENOUS HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 1994-07-27 EP disclosed
US-5300637-A Useful in determination of reducing substances MILES INC. (US) 1994-04-05 US disclosed
US-5126275-A Chromogenic reducing indicators for reducing substances such as NADH MILES INC. (US) 1992-06-30 US disclosed